Seasonal flu is emerging as a major public health concern in India, with experts estimating that the infection is linked to nearly 1.2 lakh deaths every year.
Cashless healthcare is set to transform the lives of thousands of workers in the national capital after the Delhi Cabinet approved a new healthcare scheme worth Rs 200 crore annually.
Future FTAs in the Indian pharma industry may look different as India pushes for a stronger pharmaceutical agenda in its trade negotiations.
India may be preparing for a major shift in its healthcare access as the government looks to accelerate medical devices manufacturing India and reduce the country's dependence on imported equipment.
Biotech innovation accelerates as Parexel launches its incubator, connecting early-stage therapeutics firms with clinical and regulatory expertise to bridge development gaps.
India’s drugmakers see limited gains from the minimum import price policy as weak demand, stockpiling, and slow buyer shifts delay the impact on domestic pharma manufacturing.
India has crossed a significant milestone in its healthcare journey, with organ donation pledges surpassing the 5 lakh mark.
A new Roche treatment combination has moved a step closer to the market after the US Food and Drug Administration (FDA) accepted the company’s supplemental Biologics License Application (sBLA).
India's Ebola support to African nations during the ongoing Ebola outbreak has brought renewed attention to a long-standing challenge facing the continent—its limited ability to produce vaccines locally.
The 6th Drug Safety Symposium 2026 - India Chapter, scheduled for June 24th & 25th, 2026 in Mumbai, will bring together leading voices from across the pharmacovigilance ecosystem to address one of the industry’s most pressing questions
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")